Sabra Healthcare REIT Lowered to “Underperform” at BMO Capital Markets (SBRA)
Sabra Healthcare REIT (NASDAQ:SBRA) was downgraded by analysts at BMO Capital Markets to an “underperform” rating in a research report issued to clients and investors on Thursday, StockRatingsNetwork.com reports.
Several other analysts have also recently commented on the stock. Analysts at Zacks downgraded shares of Sabra Healthcare REIT from an “outperform” rating to a “neutral” rating in a research note to investors on Tuesday. They now have a $30.00 price target on the stock. Separately, analysts at Raymond James raised their price target on shares of Sabra Healthcare REIT from $27.00 to $30.00 in a research note to investors on Friday, November 1st. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating to the company. Sabra Healthcare REIT currently has an average rating of “Hold” and an average price target of $30.60.
Sabra Healthcare REIT (NASDAQ:SBRA) traded down 0.99% during mid-day trading on Thursday, hitting $25.88. The stock had a trading volume of 300,011 shares. Sabra Healthcare REIT has a 1-year low of $21.55 and a 1-year high of $32.40. The stock’s 50-day moving average is $26.22 and its 200-day moving average is $25.25. The company has a market cap of $980.4 million and a P/E ratio of 51.25.
Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Wednesday, October 23rd. The company reported $0.46 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.46. The company had revenue of $32.90 million for the quarter, compared to the consensus estimate of $33.01 million. Analysts expect that Sabra Healthcare REIT will post $1.88 EPS for the current fiscal year.
Sabra Health Care REIT, Inc (NASDAQ:SBRA) as a wholly owned subsidiary of Sun Healthcare Group, Inc, a provider of nursing, rehabilitative and related specialty healthcare services to the senior population in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.